32833429|t|Extensive Plasmid Library to Prepare Tau Protein Variants and Study Their Functional Biochemistry.
32833429|a|Tau neurofibrillary tangles are key pathological features of Alzheimer's disease and other tauopathies. Recombinant protein technology is vital for studying the structure and function of tau in physiology and aggregation in pathophysiology. However, open-source and well-characterized plasmids for efficiently expressing and purifying different tau variants are lacking. We generated 44 sequence-verified plasmids including those encoding full length (FL) tau-441, its four-repeat microtubule-binding (K18) fragment, and their respective selected familial pathological variants (N279K, V337M, P301L, C291R, and S356T). Moreover, plasmids for expressing single (C291A), double (C291A/C322A), and triple (C291A/C322A/I260C) cysteine-modified variants were generated to study alterations in cysteine content and locations. Furthermore, protocols for producing representative tau forms were developed. We produced and characterized the aggregation behavior of the triple cysteine-modified tau-K18, often used in real-time cell internalization and aggregation studies because it can be fluorescently labeled on a cysteine outside the microtubule-binding core. Similar to the wild type (WT), triple cysteine-modified tau-K18 aggregated by progressive beta-sheet enrichment, albeit at a slower rate. On prolonged incubation, cysteine-modified K18 formed paired helical filaments similar to those in Alzheimer's disease, sharing morphological phenotypes with WT tau-K18 filaments. Nonetheless, cysteine-modified tau-K18 filaments were significantly shorter (p = 0.002) and mostly wider than WT filaments, explainable by their different principal filament elongation pathways: vertical (end-to-end) and lateral growth for WT and cysteine-modified, respectively. Cysteine rearrangement may therefore induce filament polymorphism. Together, the plasmid library, the protein production methods, and the new insights into cysteine-dependent aggregation should facilitate further studies and the design of antiaggregation agents.
32833429	37	40	Tau	Gene	4137
32833429	99	102	Tau	Gene	4137
32833429	103	126	neurofibrillary tangles	Disease	MESH:D055956
32833429	160	179	Alzheimer's disease	Disease	MESH:D000544
32833429	190	201	tauopathies	Disease	MESH:D024801
32833429	286	289	tau	Gene	4137
32833429	444	447	tau	Gene	4137
32833429	555	558	tau	Gene	4137
32833429	601	604	K18	Gene	3875
32833429	678	683	N279K	ProteinMutation	tmVar:p|SUB|N|279|K;HGVS:p.N279K;VariantGroup:3;CorrespondingGene:4137;RS#:63750756;CorrespondingSpecies:9606;CA#:225424
32833429	685	690	V337M	ProteinMutation	tmVar:p|SUB|V|337|M;HGVS:p.V337M;VariantGroup:1;CorrespondingGene:4137;RS#:63750570;CorrespondingSpecies:9606;CA#:225483
32833429	692	697	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:2;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
32833429	699	704	C291R	DNAMutation	tmVar:c|SUB|C|291|R;HGVS:c.291C>R;VariantGroup:0;CorrespondingGene:4137;RS#:776028517;CorrespondingSpecies:9606
32833429	710	715	S356T	ProteinMutation	tmVar:p|SUB|S|356|T;HGVS:p.S356T;VariantGroup:4;CorrespondingGene:3875;CorrespondingSpecies:9606
32833429	760	765	C291A	DNAMutation	tmVar:c|SUB|C|291|A;HGVS:c.291C>A;VariantGroup:0;CorrespondingGene:4137;RS#:776028517;CorrespondingSpecies:9606;CA#:8617862
32833429	776	781	C291A	DNAMutation	tmVar:c|SUB|C|291|A;HGVS:c.291C>A;VariantGroup:0;CorrespondingGene:4137;RS#:776028517;CorrespondingSpecies:9606;CA#:8617862
32833429	782	787	C322A	DNAMutation	tmVar:c|SUB|C|322|A;HGVS:c.322C>A;VariantGroup:6;CorrespondingGene:3875;CorrespondingSpecies:9606
32833429	802	807	C291A	DNAMutation	tmVar:c|SUB|C|291|A;HGVS:c.291C>A;VariantGroup:0;CorrespondingGene:4137;RS#:776028517;CorrespondingSpecies:9606;CA#:8617862
32833429	808	813	C322A	DNAMutation	tmVar:c|SUB|C|322|A;HGVS:c.322C>A;VariantGroup:6;CorrespondingGene:3875;CorrespondingSpecies:9606
32833429	814	819	I260C	ProteinMutation	tmVar:p|SUB|I|260|C;HGVS:p.I260C;VariantGroup:5;CorrespondingGene:3875;CorrespondingSpecies:9606
32833429	821	829	cysteine	Chemical	MESH:D003545
32833429	887	895	cysteine	Chemical	MESH:D003545
32833429	971	974	tau	Gene	4137
32833429	1066	1074	cysteine	Chemical	MESH:D003545
32833429	1207	1215	cysteine	Chemical	MESH:D003545
32833429	1292	1300	cysteine	Chemical	MESH:D003545
32833429	1417	1425	cysteine	Chemical	MESH:D003545
32833429	1435	1438	K18	Gene	3875
32833429	1491	1510	Alzheimer's disease	Disease	MESH:D000544
32833429	1585	1593	cysteine	Chemical	MESH:D003545
32833429	1819	1827	cysteine	Chemical	MESH:D003545
32833429	1852	1860	Cysteine	Chemical	MESH:D003545
32833429	2008	2016	cysteine	Chemical	MESH:D003545
32833429	Bind	3875	4137
32833429	Association	MESH:D000544	3875
32833429	Association	MESH:D003545	HGVS:p.S356T;CorrespondingGene:3875
32833429	Association	MESH:D055956	4137
32833429	Association	MESH:D000544	4137
32833429	Association	MESH:D024801	4137

